6,290 Procter & Gamble Company (The) $PG Shares Bought by Smith Chas P & Associates PA Cpas

Smith Chas P & Associates PA Cpas boosted its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 280,827 shares of the company’s stock after buying an additional 6,290 shares during the quarter. Procter & Gamble makes up 2.2% of Smith Chas P & Associates PA Cpas’ portfolio, making the stock its 19th largest position. Smith Chas P & Associates PA Cpas’ holdings in Procter & Gamble were worth $44,750,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Procter & Gamble during the second quarter valued at approximately $27,862,105,000. State Street Corp raised its position in Procter & Gamble by 1.0% during the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after purchasing an additional 965,461 shares in the last quarter. Bank of America Corp DE bought a new stake in Procter & Gamble during the 2nd quarter valued at $3,850,628,000. Bank of New York Mellon Corp purchased a new stake in shares of Procter & Gamble in the 2nd quarter worth $2,281,505,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Procter & Gamble by 2.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after buying an additional 300,280 shares during the period. 65.77% of the stock is currently owned by institutional investors.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Fiscal Q1 earnings per share came in at $2.00, above the roughly $1.89 analyst consensus, while revenue rose 4% year over year to $23.28 billion, exceeding expectations of approximately $22.80 billion. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Organic sales increased 4%, supported by volume growth, favorable product mix and productivity savings. Laundry and home-care products were highlighted as key contributors. P&G Q1 Earnings Beat on Volume Growth & Favorable Mix
• Positive Sentiment: P&G raised its fiscal 2027 all-in sales-growth outlook, primarily reflecting the acquisition of Thorne. Management also reiterated its broader full-year revenue forecast, reducing concern that consumer weakness would derail the business. Procter & Gamble Boosts FY27 All-in-sales Growth Outlook
• Positive Sentiment: Investors appeared to favor P&G’s defensive characteristics as broader markets weakened, while increased call-option activity reflected stronger near-term trading interest. P&G Jumps as Earnings Beat Draws Defensive Buyers
• Neutral Sentiment: Management said changing demographics may support premium baby-care demand: fewer children per household can lead parents to spend more on each child, benefiting products such as Pampers. Americans are having fewer babies and pampering them with luxury diapers
• Negative Sentiment: Higher commodity and fuel costs are expected to create an approximately $1.4 billion annual profit headwind, which could pressure margins even as sales remain healthy. P&G flags bigger hit to annual profit from higher commodity costs

Procter & Gamble Stock Up 5.8%

Shares of NYSE PG opened at $165.94 on Friday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The stock’s fifty day simple moving average is $148.08 and its two-hundred day simple moving average is $146.99. The stock has a market capitalization of $385.41 billion, a PE ratio of 25.07, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. The firm had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.99 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.6%. Procter & Gamble’s payout ratio is currently 65.71%.

Insiders Place Their Bets

In other Procter & Gamble news, CFO Andre Schulten sold 3,914 shares of the stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the sale, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at approximately $9,536,920.12. This represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $323,381.50. Following the sale, the chief executive officer directly owned 51,124 shares of the company’s stock, valued at approximately $7,430,362.16. The trade was a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 15,135 shares of company stock valued at $2,189,970 in the last three months. 0.23% of the stock is currently owned by insiders.

Analysts Set New Price Targets

PG has been the topic of a number of recent research reports. Royal Bank Of Canada reissued an “outperform” rating and set a $166.00 price target on shares of Procter & Gamble in a research report on Tuesday. Citigroup lifted their price objective on Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a report on Friday, October 9th. Jefferies Financial Group upped their price objective on shares of Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research note on Friday, June 26th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $149.00 price objective on shares of Procter & Gamble in a research note on Monday, August 24th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, July 16th. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $162.50.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.